Stonebridge Capital Advisors’s Teladoc Health TDOC Stock Holding History

Stonebridge Capital Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10	Closed	-$186	–	783
2023 Q3	$186	Hold	10	–	–	﹤0.01%	899
2023 Q2	$253	Sell	10 -5	-33%	-$126	﹤0.01%	901
2023 Q1	$389	Hold	15	–	–	﹤0.01%	903
2022 Q4	$355	Hold	15	–	–	﹤0.01%	919
2022 Q3	$0	Hold	15	–	–	﹤0.01%	1117
2022 Q2	$0	Sell	15 -3	-17%	-$127	﹤0.01%	1077
2022 Q1	$1K	Hold	18	–	–	﹤0.01%	992
2021 Q4	$2K	Sell	18 -6	-25%	-$717	﹤0.01%	879
2021 Q3	$3K	Buy	24 +13	+118%	+$1.89K	﹤0.01%	786
2021 Q2	$2K	Hold	11	–	–	﹤0.01%	815
2021 Q1	$2K	Buy	+11	New	+$2.55K	﹤0.01%	861
2020 Q1	–	Sell	-7	Closed	-$1K	–	854
2019 Q4	$1K	Hold	7	–	–	﹤0.01%	819
2019 Q3	$0	Hold	7	–	–	﹤0.01%	938
2019 Q2	$0	Buy	+7	New	+$408	﹤0.01%	923

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stonebridge Capital Advisors's TDOC Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Teladoc Health (TDOC) in Q4 2023, closing a stake of 10 shares — an estimated $186 sold.

Stonebridge Capital Advisors first reported a position in TDOC in Q2 2019 and held it in 14 quarters. The position peaked at $3K in Q3 2021. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

Stonebridge Capital Advisors reported no remaining Teladoc Health position as of Q4 2023 after selling out during the quarter.
Stonebridge Capital Advisors sold 10 Teladoc Health shares in Q4 2023, an estimated $186.
Stonebridge Capital Advisors first reported a position in Teladoc Health in Q2 2019 and held it in 14 quarters.
Stonebridge Capital Advisors's Teladoc Health position peaked at $3K in Q3 2021.
435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.